Compumedics Limited (ASX:CMP)
0.2550
0.00 (0.00%)
Aug 28, 2026, 1:18 PM AEST
Compumedics Revenue
In the fiscal year ending June 30, 2026, Compumedics had annual revenue of 61.88M AUD with 21.23% growth. Compumedics had revenue of 30.90M in the half year ending June 30, 2026, with 29.57% growth.
Revenue
61.88M
Revenue Growth
+21.23%
P/S Ratio
0.82
Revenue / Employee
353.58K
Employees
175
Market Cap
50.94M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 61.88M | 10.84M | 21.23% |
| Jun 30, 2025 | 51.04M | 778.00K | 1.55% |
| Jun 30, 2024 | 50.26M | 7.34M | 17.10% |
| Jun 30, 2023 | 42.92M | 4.32M | 11.18% |
| Jun 30, 2022 | 38.61M | 2.87M | 8.02% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SomnoMed | 118.50M |
| Cyclopharm | 34.42M |
| Nova Eye Medical | 33.05M |
| CleanSpace Holdings | 20.66M |
| Lumos Diagnostics Holdings | 18.31M |
| Micro-X | 16.90M |
| Control Bionics | 6.07M |
| OncoSil Medical | 3.72M |